What is a CentriMag LVAD?

CentriMag is an external blood pump, connected to a surgically inserted cannula. It is designed for short‑term cardiopulmonary support (up to 30 days) in adults and children with end-stage or acute heart failure.

What is a BiVAD?

A biventricular assist device (BIVAD) is a mechanical device that supports both lower heart chambers (ventricles).

How long can a person live with a LVAD?

Q: How long does the LVAD last? A: The longest device has been in a patient for about 7 years. Testing by the manufacturers suggests that the LVAD should provide support for at least 10 years.

What is a right ventricular assist device?

A ventricular assist device helps your heart pump blood when the pumping muscle has become weak. A right ventricular assist device (RVAD) pumps blood from your right ventricle or right atrium into your pulmonary artery and to the lungs.

What is a tandem heart?

The Tandem Heart® Percutaneous Ventricular Assist Device (pVAD)™ system (Cardiac Assist, Inc.; Pittsburgh, Pa) uses a transseptal cannula that allows direct unloading of the left heart at blood flow rates sufficient to sustain patients.

What does Impella RP stand for?

The percutaneous mechanical circulatory support device, Impella RP (Abiomed, Danvers, Mass.), provides the opportunity for early intervention in the downward spiral of medically refractory RVF.

What is total artificial heart?

A total artificial heart (TAH) is a pump that is surgically installed to provide circulation and replace heart ventricles that are diseased or damaged. The ventricles pump blood out of the heart to the lungs and other parts of the body.

What is biventricular heart failure?

Biventricular heart failure: In biventricular heart failure, both sides of the heart are affected. This can cause the same symptoms as both left-sided and right-sided heart failure, such as shortness of breath and a build-up of fluid.

What is the longest someone has lived with an LVAD?

David Pierce has the distinguished recognition of being the longest living HeartMate II LVAD patient in the U.S. David received his first LVAD on May 26, 2004, at the age of 52. Today, he is living a happy, healthy life — and spending precious time with his family.

How successful is LVAD surgery?

The overall survival on LVAD support was 86.1%, 56.0%, and 30.9% at 30 days, 1 year, and 2 years after LVAD implantation, respectively, as shown in Figure 1. A total of 155 of 280 patients (55%) died during the mean support time of 10.4 months (range, 1 day to 3.6 years).

Is VAD a disease?

The severity of your heart failure is appropriate for a VAD . You have other serious medical conditions that may affect your health or quality of life with a VAD . You need support for the left ventricle, the right ventricle or both ventricles. You’re able to take blood-thinning medications for a long period of time.

Is Tandem heart ECMO?

Our experience suggests that the TandemHeart catheter system can offer innovative and superior options for ECMO delivery to different populations of patients who experience cardiopulmonary failure.

What are the surgical steps in CentriMag biventricular assist device?

Surgical Steps In CentriMag Biventricular Assist Device (BiVAD) Placement. CentriMag devices are implanted for acute right and/or left-sided circulatory support but often times used for extended periods of time for patients with acute heart failure awaiting a heart transplant.

Can a Centrimag be used for a long-term VAD?

CentriMag is a versatile and reliable ventricular assist device. It can provide uni- and biventricular support for bridging patients to recovery, heart transplantation or long-term VAD. Its use beyond 30 days is possible, safe and associated with a low impact on complications and mortality.

Can a CentriMag BiVAD be used for a heart transplant?

Pediatric application of the Thoratec CentriMag BiVAD as a bridge to heart transplantation. J Thorac Cardiovasc Surg 2008;136:1386-1387. .

What is the clinical use of the Centrimag system?

Clinical experience using the Levitronix CentriMag System for temporary right ventricular mechanical circulatory support A single-center retrospective analysis of 29 patients who received CentriMag System for right ventricular (RV) support for cardiogenic shock post-cardiotomy (24%), post-cardiac transplant (35%), and post-LVAD placement (41%).